Shreas is a partner at IVP (Institutional Venture Partners) focusing on AI investments. Recent bets include Sunno (AI music) and Anthropic (frontier models), plus an unnamed protein-model company for drug discovery. He emphasizes frontier intelligence durability and avoiding local-maximum investing.
no scored calls yet — needs a stated position or a categorical verdict, with a matured window vs SPY
Sunno enables anyone to create high-quality music across languages, democratizing music production with a consumer-facing AI application that shows strong engagement even from non-artistic users.
Frontier foundation models will maintain a durable premium for high-stakes use cases like drug discovery, while open-source models serve commodity tasks; both ecosystems will coexist and create value.
Frontier AI models applied to protein design can optimize and develop better drugs for pharma, representing a high-value application where expensive frontier intelligence is justified by the importance of solving diseases like cancer.